NeoVax with nivolumab proved feasible in a phase 1 ovarian cancer trial, with acceptable safety and T-cell responses. Noted carefully, without efficacy claims.
Trending
- Noted: Saturn’s 274 Moons Are Mostly Captured Fragments
- Neoantigen Vaccine Notes: Feasible, Safe, Unproven
- Kitchen Heating Problems and Oven Repair Round Rock TX Solutions
- How Technology Is Changing the Detection of Breast Cancer
- How the 3D Folding of DNA May Explain Cephalopods’ Complex Brains
- Understanding the BDGNET Game Experience
- CES 2025: Everyday Life Transformed by AI Gadgets
- Quantum Leaps 2025: Vision to Innovation
